HAE
Price
$75.45
Change
-$1.45 (-1.89%)
Updated
Dec 20, 04:59 PM (EDT)
51 days until earnings call
NEOG
Price
$12.04
Change
+$0.02 (+0.17%)
Updated
Dec 20, 04:59 PM (EDT)
18 days until earnings call
Ad is loading...

HAE vs NEOG

Header iconHAE vs NEOG Comparison
Open Charts HAE vs NEOGBanner chart's image
Haemonetics
Price$75.45
Change-$1.45 (-1.89%)
Volume$5.15K
CapitalizationN/A
Neogen
Price$12.04
Change+$0.02 (+0.17%)
Volume$30.79K
CapitalizationN/A
HAE vs NEOG Comparison Chart
Loading...
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HAE vs. NEOG commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HAE is a Hold and NEOG is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (HAE: $75.44 vs. NEOG: $12.04)
Brand notoriety: HAE and NEOG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HAE: 245% vs. NEOG: 237%
Market capitalization -- HAE: $4.33B vs. NEOG: $3.42B
HAE [@Medical Specialties] is valued at $4.33B. NEOG’s [@Medical Specialties] market capitalization is $3.42B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HAE’s FA Score shows that 0 FA rating(s) are green whileNEOG’s FA Score has 1 green FA rating(s).

  • HAE’s FA Score: 0 green, 5 red.
  • NEOG’s FA Score: 1 green, 4 red.
According to our system of comparison, HAE is a better buy in the long-term than NEOG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HAE’s TA Score shows that 4 TA indicator(s) are bullish while NEOG’s TA Score has 4 bullish TA indicator(s).

  • HAE’s TA Score: 4 bullish, 6 bearish.
  • NEOG’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both HAE and NEOG are a bad buy in the short-term.

Price Growth

HAE (@Medical Specialties) experienced а -7.08% price change this week, while NEOG (@Medical Specialties) price change was -0.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

HAE is expected to report earnings on Feb 11, 2025.

NEOG is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HAE($4.34B) has a higher market cap than NEOG($3.42B). NEOG has higher P/E ratio than HAE: NEOG (150.80) vs HAE (34.47). HAE YTD gains are higher at: -11.776 vs. NEOG (-40.129). HAE has higher annual earnings (EBITDA): 264M vs. NEOG (189M). NEOG has more cash in the bank: 230M vs. HAE (194M). HAE (871M) and NEOG (889M) have identical debt. HAE has higher revenues than NEOG: HAE (1.27B) vs NEOG (919M).
HAENEOGHAE / NEOG
Capitalization4.34B3.42B127%
EBITDA264M189M140%
Gain YTD-11.776-40.12929%
P/E Ratio34.47150.8023%
Revenue1.27B919M138%
Total Cash194M230M84%
Total Debt871M889M98%
FUNDAMENTALS RATINGS
HAE vs NEOG: Fundamental Ratings
HAE
NEOG
OUTLOOK RATING
1..100
7262
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5889
PRICE GROWTH RATING
1..100
6289
P/E GROWTH RATING
1..100
463
SEASONALITY SCORE
1..100
n/a4

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HAE's Valuation (74) in the Medical Specialties industry is in the same range as NEOG (96). This means that HAE’s stock grew similarly to NEOG’s over the last 12 months.

HAE's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NEOG (100). This means that HAE’s stock grew similarly to NEOG’s over the last 12 months.

HAE's SMR Rating (58) in the Medical Specialties industry is in the same range as NEOG (89). This means that HAE’s stock grew similarly to NEOG’s over the last 12 months.

HAE's Price Growth Rating (62) in the Medical Specialties industry is in the same range as NEOG (89). This means that HAE’s stock grew similarly to NEOG’s over the last 12 months.

NEOG's P/E Growth Rating (3) in the Medical Specialties industry is somewhat better than the same rating for HAE (46). This means that NEOG’s stock grew somewhat faster than HAE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HAENEOG
RSI
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 5 days ago
72%
Momentum
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 13 days ago
68%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 7 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
52%
Aroon
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
77%
View a ticker or compare two or three
Ad is loading...
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DUSL57.081.83
+3.31%
Direxion Dly Industrials Bull 3X ShsETF
USMF50.390.63
+1.26%
WisdomTree US Multifactor
CVY25.120.31
+1.24%
Invesco Zacks Multi-Asset Income ETF
ACIO40.480.37
+0.92%
Aptus Collared Investment Opp ETF
KDRN23.57N/A
N/A
Kingsbarn Tactical Bond ETF

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with OM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then OM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
-1.90%
OM - HAE
40%
Loosely correlated
+9.01%
GH - HAE
40%
Loosely correlated
+1.73%
CRL - HAE
32%
Poorly correlated
+1.99%
A - HAE
31%
Poorly correlated
+0.99%
NEOG - HAE
29%
Poorly correlated
+0.17%
More

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with CRL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
+0.17%
CRL - NEOG
45%
Loosely correlated
+1.99%
ICUI - NEOG
44%
Loosely correlated
+2.36%
TWST - NEOG
41%
Loosely correlated
+9.90%
MASS - NEOG
40%
Loosely correlated
+6.19%
VCYT - NEOG
40%
Loosely correlated
+4.66%
More